ArticleBMC genomics2026
Matrix metalloproteinase 2 governs extracellular matrix remodeling during ovarian development in a viviparous teleost Sebastes schlegelii (Hilgendorf, 1880).
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSebastes schlegelii (Hilgendorf, 1880), a viviparous fish with annual ovarian remodeling, shows marked activation of Extracellular Matrix (ECM)-receptor interaction signaling post-mating. However, the evolutionary conservation and functional significance of a key ECM remodeler-Matrix metalloproteinase 2 (MMP2) in this unique reproductive system are poorly understood.
resultsIn this study, we identified the core members of the MMP family from the S. schlegelii genome and investigated their expression patterns and localization in ovarian tissues. The results demonstrated that the gelatinase gene mmp2 (Ssc_10020200) displayed high expression levels in the mated ovaries, with its expression being predominantly located in the ovarian follicular cell layers and follicular placenta and embryos. Both in vitro and in vivo experiments revealed that MMP2 knockdown during the vitellogenic and gestation stages led to significant ovarian developmental abnormalities. Furthermore, MMP2 knockdown induced a reduction in ECM components such as COL4Α1, LAMB1, and FN1B, accompanied by enhanced apoptotic signaling.
conclusionsThis study suggests that MMP2 plays a vital role in modulating ECM remodeling and maintaining ovarian tissue homeostasis, further ensuring normal ovarian development and healthy reproductive processes. Our findings elucidate a critical function for MMP2 in ovarian development of viviparous teleost, and may inspire further strategies to enhance fish reproductive health and aquaculture outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.